Strattera and Actemra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Actemra (tocilizumab). Common drug interactions include sinusitis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Actemra. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 102,759 Actemra users. Check the latest studies of Actemra.

On Jul, 13, 2026

25 people who take Strattera and Actemra together, and have interactions are studied.

Strattera and Actemra drug interactions.

What are the common drug interactions of Strattera and Actemra, by gender? *:

female:

Sinusitis (inflammation of sinus)
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Neurogenic shock (insufficient blood flow throughout the body due to injury in spinal cord)
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Arthralgia (joint pain)
Cough
Drug ineffective
Hypersensitivity

male:

Arthralgia (joint pain)
Blood pressure diastolic decreased
Oropharyngeal pain
Oxygen saturation decreased
Rash
Spinal disorder (disease of spine a back bone)
Tonsillar haemorrhage (bleeding from tonsil)
Weight increased
Hallucination (an experience involving the perception of something not present)
Oesophageal spasm (contraction of oesophagus)

What are the common drug interactions of Strattera and Actemra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Arthralgia (joint pain)
Blood pressure diastolic decreased
Blood pressure diastolic increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest pain
Cough
Heart rate increased
Hypotension (abnormally low blood pressure)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Arthralgia (joint pain)
Cough
Weight increased
Drug ineffective
Hypersensitivity
Hypersensitivity pneumonitis
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Sinusitis (inflammation of sinus)

60+:

n/a

What are the existing conditions these people have? *

Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 23 people, 92.00%
Cough: 17 people, 68.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 16 people, 64.00%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Actemra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously